AACR Annual Meeting 2025

Join us at the AACR Annual Meeting to explore how the OhmX Platform, powered by electronic genome mapping (EGM), is redefining structural variant (SV) detection in cancer research.

SVs—including deletions, duplications, translocations, and complex events like chromothripsis—play a key role in cancer development and progression. Traditional sequencing often falls short in capturing these alterations. EGM delivers a comprehensive view of genomic architecture, enabling precise detection of even the most cryptic rearrangements.

Book a meeting to chat with experts and learn how OhmX supports research in cancer biology, cytogenetics, rare disease, and cell and gene therapy.

To learn more about electronic genome mapping, visit nabsys.com/electronic-genome-mapping.

‍